46
Growth Score
pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1046592
BioComo is a biotechnology company that is engaged in the research and development of biopharmaceuticals and bioproducts.
- Masayuki Fukumura: Representative Director and Founder
About the Company
BioComo develops next-generation vaccines using its proprietary BC-PIV viral vector platform. This technology combines the high cell adhesion properties of live viruses with the safety of inactivated viruses, enabling effective delivery of antigens for infectious diseases and cancer. It advances intranasal vaccines, including candidates for RSV and
COVID-19, collaborating with institutions like Mie University and TFBS Bioscience.
